Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab … Read more
Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals. Even as India’s cumulative Covid-19 vaccination coverage exceeds 75.89 Crore, Covid-19 vaccination of children with comorbidities in the 12 to 17 … Read more
Ella countered this saying that as per the clearance Bharat Biotech would monitor each person getting the vaccine — as they would in a clinical trial. Bharat Biotech’s Covid-19 vaccine, Covaxin, has already been administered to 6,000 volunteers during its Phase 3 trial, the company’s founder and chairman, Dr Krishna Ella, said on Monday. The … Read more
COVID vaccine: To other question on the amount of stock of vaccines already made and ready, he said, the company has a stockpile of 20 million doses and has plans to ramp up production to 700 million doses from four plants so supply should not be a problem. (Representational photo/Reuters/File Photo) At 5 pm on … Read more
Bharat Biotech coronavirus vaccine Covaxin update: A medic fills a syringe with COVAXIN, COVID-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad. (Reuters/File Photo) Bharat Biotech Covid-19 vaccine Covaxin update: Bharat Biotech’s chairman Krishna Ella hit out at critics on Monday saying … Read more